Adhesion molecules during adverse events after human liver transplantation.
Mueller
A R
AR
Department of Surgery, Virchow Clinic, Humboldt University of Berlin, Germany.
Platz
K P
KP
Haller
G W
GW
Schumacher
G
G
Rayes
N
N
Schumacher
C
C
Neuhaus
P
P
D015415:Biomarkers / Q000097:blood; D015815:Cell Adhesion Molecules / Q000097:blood*; D004359:Drug Therapy, Combination; D019040:E-Selectin / Q000097:blood; D006084:Graft Rejection / Q000097:blood / Q000175:diagnosis / Q000276:immunology*; D006085:Graft Survival; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood; D008099:Liver; D016031:Liver Transplantation / Q000276:immunology* / Q000401:mortality; D009926:Organ Preservation; D011183:Postoperative Complications / Q000453:epidemiology / Q000276:immunology; D011446:Prospective Studies; D015996:Survival Rate; D019010:Vascular Cell Adhesion Molecule-1 / Q000097:blood
D015415:Biomarkers; D015815:Cell Adhesion Molecules; D019040:E-Selectin; D007166:Immunosuppressive Agents; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1